VSL Reaches $20M Deal Resolving Knockoff Probiotic Claims
VSL Pharmaceuticals Inc., Sigma-Tau Pharmaceuticals Inc. and Alfasigma USA Inc. have reached a $20 million settlement with customers who bought a knockoff version of a proprietary probiotic formula for gastrointestinal ailments,...To view the full article, register now.
Already a subscriber? Click here to view full article